Bumjin Lim

651 citations
64 papers · 410 · 1 hit paper · h-index 12

Impact in

    • Renal cell carcinoma treatment
    • Prostate Cancer Diagnosis and Treatment
    • Prostate Cancer Treatment and Research
  • Urology top 10%
    • Urinary Bladder and Prostate Research

Papers in

    • Prostate Cancer Diagnosis and Treatment 19
    • Prostate Cancer Treatment and Research 9
    • Renal cell carcinoma treatment 8
    • Bladder and Urothelial Cancer Treatments 11

Bumjin Lim

54 papers receiving 404 citations

Bumjin Lim's Hit Papers

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study 2024 · 99 citations
990+1Years since publication255075

Peers

Bumjin Lim
Comparison fields: 5 of 60
  • Pulmonary and Respiratory Medicine 191
  • Urology 29
  • Biotechnology 18
  • Cancer Research 29
  • Oncology 34
Replace Ioan Coman with:
Ioan Coman Romania
Daniel Baumunk Germany
Angelica A. C. Grasso Italy
Zoltán Bajory Hungary
Ronald L. Yap United States
Marília Germanos de Castro Brazil
W. A. See United States
Renato Beluco Corradi United States
Stephan Degener Germany
Alfonso Crisci Italy
Bumjin Lim relative to Ioan Coman Romania Ioan Coman's profile →
Citations per field
00.5×2×3×3.9×
Ioan Coman · 1×
Citations per year

Countries citing papers authored by Bumjin Lim

Since Specialization
Citations

This map shows the geographic impact of Bumjin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bumjin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bumjin Lim more than expected).

Fields of papers citing papers by Bumjin Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bumjin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bumjin Lim. The network helps show where Bumjin Lim may publish in the future.

Co-authors

The 25 scholars most cited alongside Bumjin Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bumjin Lim Line = papers co-authored together Bumjin Lim links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Hit paper breakdown →
202499
2 202122
3 201419
4 202016
5 202316
6 202416
7 201415
8 201513
9 201513
10 201912
11 202012
12 202112
13 202011
14 202010
15 20219
16 20219
17 20229
18 20249
19 20207
20 20146

About Bumjin Lim

Bumjin Lim is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Biotechnology, Cancer Research and Urology, having authored 64 papers that have together received 410 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (19 papers), Bladder and Urothelial Cancer Treatments (11 papers), Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (8 papers), Microbial Inactivation Methods (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Epigenetics and DNA Methylation (3 papers) and Urinary Bladder and Prostate Research (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (191 citations), Urology (29 citations), Biotechnology (18 citations), Cancer Research (29 citations) and Oncology (34 citations). Bumjin Lim has collaborated with scholars based in South Korea, United States and Vietnam. Frequent co-authors include Choung‐Soo Kim, In Gab Jeong, Jun Hyuk Hong, Dalsan You, Bumsik Hong, Myung‐Soo Choo, Yoon Soo Kyung, Miho Song, Hanjong Ahn and Won‐Chul Lee. Their work appears in journals such as Scientific Reports, Prostate International, Journal of Cancer Research and Clinical Oncology, Urologic Oncology Seminars and Original Investigations and Cancer Research and Treatment.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact